ARCHIVES

Obituary: Ellen Tobin, Consultant, Championed Patients’ Needs;

This article is from The Cancer Letter archive.

Vol. 29 No. 02 | January 10, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

Contact Planned To Encourage Insurers To Reimburse For Cancer Screening

November 28, 1975

NCI Offers 200 Cell Lines to Scientist

May 6, 1983

After Furlough, Blizzard, NCI Struggles to Clear Backlog and Resume Business

January 19, 1996